Bingchen Zhang - Search Results

Year	Number of Results
2017	1
2018	1
2019	6
2020	4
2021	3
2022	1

1

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.

Chen F, Fang Y, Zhao R, Le J, Zhang B, Huang R, Chen Z, Shao J. Chen F, et al. Among authors: zhang b. Eur J Med Chem. 2019 Oct 1;179:916-935. doi: 10.1016/j.ejmech.2019.06.070. Epub 2019 Jun 28. Eur J Med Chem. 2019. PMID: 31306818 Review.

2

Accelerating transdermal delivery of insulin by ginsenoside nanoparticles with unique permeability.

Zou JJ, Le JQ, Zhang BC, Yang MY, Jiang JL, Lin JF, Wu PY, Li C, Chen L, Shao JW. Zou JJ, et al. Int J Pharm. 2021 Aug 10;605:120784. doi: 10.1016/j.ijpharm.2021.120784. Epub 2021 Jun 8. Int J Pharm. 2021. PMID: 34111544

3

Accurate Wide Angle SAR Imaging Based on LS-CS-Residual.

Wei Z, Zhang B, Wu Y. Wei Z, et al. Among authors: zhang b. Sensors (Basel). 2019 Jan 25;19(3):490. doi: 10.3390/s19030490. Sensors (Basel). 2019. PMID: 30691042 Free PMC article.

4

A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy.

Zhang B, Jiang J, Wu P, Zou J, Le J, Lin J, Li C, Luo B, Zhang Y, Huang R, Shao J. Zhang B, et al. Acta Pharm Sin B. 2021 Jan;11(1):246-257. doi: 10.1016/j.apsb.2020.07.026. Epub 2020 Aug 19. Acta Pharm Sin B. 2021. PMID: 33532190 Free PMC article.

5

The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications.

Luo BY, Jiang JL, Fang YF, Yang F, Yin MD, Zhang BC, Zhao RR, Shao JW. Luo BY, et al. Pharmacol Res. 2020 Sep;159:105031. doi: 10.1016/j.phrs.2020.105031. Epub 2020 Jun 17. Pharmacol Res. 2020. PMID: 32562816 Review.

6

Comparison of Raw Data-Based and Complex Image-Based Sparse SAR Imaging Methods.

Xu Z, Zhang B, Bi H, Wu C, Wei Z. Xu Z, et al. Among authors: zhang b. Sensors (Basel). 2019 Jan 15;19(2):320. doi: 10.3390/s19020320. Sensors (Basel). 2019. PMID: 30650524 Free PMC article.

7

Carrier-free nanodrugs for in vivo NIR bioimaging and chemo-photothermal synergistic therapy.

Lin J, Li C, Guo Y, Zou J, Wu P, Liao Y, Zhang B, Le J, Zhao R, Shao JW. Lin J, et al. Among authors: zhang b. J Mater Chem B. 2019 Nov 28;7(44):6914-6923. doi: 10.1039/c9tb00687g. Epub 2019 Sep 4. J Mater Chem B. 2019. PMID: 31482166

8

Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.

Zhang BC, Luo BY, Zou JJ, Wu PY, Jiang JL, Le JQ, Zhao RR, Chen L, Shao JW. Zhang BC, et al. ACS Appl Mater Interfaces. 2020 Dec 23;12(51):57362-57372. doi: 10.1021/acsami.0c17660. Epub 2020 Dec 10. ACS Appl Mater Interfaces. 2020. PMID: 33301289

9

A study to evaluate herb-drug interaction underlying mechanisms: An investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases.

Lin JF, Fan LL, Li BW, Zhao RR, Jiang LG, Zhang BC, Lu YS, Shao JW. Lin JF, et al. Eur J Pharm Sci. 2020 Jan 15;142:105100. doi: 10.1016/j.ejps.2019.105100. Epub 2019 Oct 25. Eur J Pharm Sci. 2020. PMID: 31669385

10

Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.

Fan L, Zhang B, Xu A, Shen Z, Guo Y, Zhao R, Yao H, Shao JW. Fan L, et al. Among authors: zhang b. Mol Pharm. 2018 Jun 4;15(6):2466-2478. doi: 10.1021/acs.molpharmaceut.8b00444. Epub 2018 May 15. Mol Pharm. 2018. PMID: 29727577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results